titanium dioxide has been researched along with Leukemia, Myeloid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, YQ; Li, X; Liu, J; Lü, S; Luo, Q; Wang, F; Wu, J; Xiong, S | 1 |
1 other study(ies) available for titanium dioxide and Leukemia, Myeloid
| Article | Year |
|---|---|
Inhibitor screening of protein kinases using MALDI-TOF MS combined with separation and enrichment of phosphopeptides by TiO2 nanoparticle deposited capillary column.
Topics: Antineoplastic Agents; Benzamides; Chronic Disease; Drug Screening Assays, Antitumor; Humans; Imatinib Mesylate; Leukemia, Myeloid; Nanoparticles; Phosphopeptides; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium | 2010 |